weight regain after stopping glp-1 agonists Ozempic, Wegovy & Mounjaro: What to Know Key Facts GPs Should Know
Description
What is the difference between semaglutide and tirzepatide
As soon as they develop PDR, they should be referred to an ophthalmologist for management with either anti-VEGF injections or panretinal photocoagulation to prevent vision loss
This can lead to reduced expression of GLP- 1 receptors and the development of GLP- 1 resistance
JAMA 2025;333:1062-73.ArticlePubMedPMC 136
